Alan Krasner

1.3k total citations
53 papers, 899 citations indexed

About

Alan Krasner is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Alan Krasner has authored 53 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Alan Krasner's work include Pituitary Gland Disorders and Treatments (23 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Thyroid and Parathyroid Surgery (9 papers). Alan Krasner is often cited by papers focused on Pituitary Gland Disorders and Treatments (23 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Thyroid and Parathyroid Surgery (9 papers). Alan Krasner collaborates with scholars based in United States, Brazil and Germany. Alan Krasner's co-authors include Deborah Finco‐Kent, S Edwin Fineberg, Thomas T. Kawabata, Robert J. Fountaine, Gregory L. Finch, Kristina Chen, Tim Heise, John P. Bilezikian, B.L. Clarke and Tamara Vokes and has published in prestigious journals such as JAMA, Nucleic Acids Research and Endocrine Reviews.

In The Last Decade

Alan Krasner

43 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Krasner United States	17	582	377	196	161	124	53	899
Rose C. Christian United States	11	233 0.4×	111 0.3×	136 0.7×	38 0.2×	68 0.5×	17	723
Lionel Badet France	17	85 0.1×	617 1.6×	92 0.5×	74 0.5×	42 0.3×	47	839
Rossana Caldara Italy	16	190 0.3×	463 1.2×	170 0.9×	25 0.2×	32 0.3×	65	751
Maja Cigrovski Berković Croatia	17	510 0.9×	210 0.6×	187 1.0×	39 0.2×	11 0.1×	82	914
H. Kotzmann Austria	13	296 0.5×	45 0.1×	65 0.3×	33 0.2×	96 0.8×	26	816
Blaise Robin France	13	128 0.2×	87 0.2×	34 0.2×	70 0.4×	64 0.5×	25	571
Pedro Leão Neves Portugal	14	77 0.1×	97 0.3×	62 0.3×	55 0.3×	319 2.6×	55	604
Della Cole United Kingdom	10	103 0.2×	179 0.5×	66 0.3×	48 0.3×	20 0.2×	17	641
Kentaro Omori Japan	13	42 0.1×	106 0.3×	168 0.9×	68 0.4×	428 3.5×	23	678
Antonios Kattamis Greece	15	67 0.1×	94 0.2×	46 0.2×	42 0.3×	27 0.2×	57	848

Countries citing papers authored by Alan Krasner

Since Specialization

Citations

This map shows the geographic impact of Alan Krasner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Krasner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Krasner more than expected).

Fields of papers citing papers by Alan Krasner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Krasner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Krasner. The network helps show where Alan Krasner may publish in the future.

Co-authorship network of co-authors of Alan Krasner

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Krasner. A scholar is included among the top collaborators of Alan Krasner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Krasner. Alan Krasner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biller, Beverly M. K., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2025). OR12-07 Disease Control in Patients With Acromegaly Switching From Injected Somatostatin Receptor Ligands to Once-Daily Oral Paltusotine: Interim Results of the PATHFNDR-1 Open-Label Extension. Journal of the Endocrine Society. 9(Supplement_1).

Bachega, Tânia A.S.S., Jamie Marko, Darío Bruera, et al.. (2025). SAT-452 Reductions in Adrenal Volume in Patients With Congenital Adrenal Hyperplasia Receiving Once-Daily Oral Atumelnant (CRN04894): Interim Results From a 12-Week, Phase 2, Open-Label Study. Journal of the Endocrine Society. 9(Supplement_1).

Madan, Ajay, et al.. (2025). Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. British Journal of Clinical Pharmacology. 91(7). 2070–2079.

Gadelha, Mônica R., Атанаска Еленкова, César Luiz Boguszewski, et al.. (2025). MON-069 Once-daily Oral Paltusotine In The Treatment Of Patients With Biochemically Uncontrolled Acromegaly: Interim Results Of The PATHFNDR-2 Open-label Extension. Journal of the Endocrine Society. 9(Supplement_1).

Reisch, Nicole, Richard J. Auchus, Umasuthan Srirangalingam, et al.. (2025). SUN-438 Rapid And Sustained Reduction Of 11-oxygenated Androgens In Adults With Classic Congenital Adrenal Hyperplasia Following Once-daily Oral Atumelnant (CRN04894): Results From A 12-week, Phase 2, Open-label Study. Journal of the Endocrine Society. 9(Supplement_1).

Gadelha, Mônica R., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2024). Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. The Journal of Clinical Endocrinology & Metabolism. 110(1). 228–237. 12 indexed citations

Biller, Beverly M. K., Атанаска Еленкова, César Luiz Boguszewski, et al.. (2024). 12535 Efficacy And Safety Of Once-daily Oral Paltusotine In Medically Untreated Patients With Acromegaly: Results From The Phase 3, Randomized, Placebo-controlled Pathfndr-2 Study. Journal of the Endocrine Society. 8(Supplement_1). 5 indexed citations

Auchus, Richard J., Peter Trainer, Kathryn Jean Lucas, et al.. (2024). 12537 Once Daily Oral Atumelnant (CRN04894) Induces Rapid And Profound Reductions Of Androstenedione And 17-Hydroxyprogesterone In Participants With Classical Congenital Adrenal Hyperplasia: Initial Results From A 12-Week, Phase 2, Open-Label Study. Journal of the Endocrine Society. 8(Supplement_1). 3 indexed citations

Moore, Christopher A., Alejandro Ayala, Yongning Wu, et al.. (2024). 9330 Atumelnant (crn04894) Induces Rapid And Sustained Reductions In Serum And Urine Cortisol In Patients With Acth-Dependent Cushing Syndrome During A Phase 1b/2a, Single Center, 10-day, Inpatient, Open-Label Study. Journal of the Endocrine Society. 8(Supplement_1).

10.

Gadelha, Mônica R., Harpal Randeva, Murray B. Gordon, et al.. (2023). OR01-01 Oral, Once-daily, Paltusotine (Non-peptide Selective Somatostatin Receptor Subtype 2 Agonist) Therapy In Patients With Acromegaly Is Associated With Long-term Biochemical And Symptom Control And Is Preferred Over Injectable Somatostatin-Receptor Ligands. Journal of the Endocrine Society. 7(Supplement_1). 3 indexed citations

11.

Gadelha, Mônica R., Murray B. Gordon, Mirjana Doknić, et al.. (2022). ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 108(5). e148–e159. 19 indexed citations

12.

Chen, Kristina, et al.. (2019). Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review. Journal of Medical Economics. 22(11). 1141–1152. 25 indexed citations

13.

Coles, Theresa, Kristina Chen, Lauren Nelson, et al.. (2019). <p>Psychometric evaluation of the hypoparathyroidism symptom diary</p>. Patient Related Outcome Measures. Volume 10. 25–36. 20 indexed citations

14.

Vokes, Tamara, Michael Mannstadt, Michael A. Levine, et al.. (2017). Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 103(2). 722–731. 52 indexed citations

15.

Bilezikian, John P., B.L. Clarke, Michael Mannstadt, et al.. (2017). Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-μg or 50-μg Daily Doses. Clinical Therapeutics. 39(10). 2096–2102. 17 indexed citations

16.

Cefalu, William T., Nancy J.V. Bohannon, S Edwin Fineberg, et al.. (2008). Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy. Current Medical Research and Opinion. 24(11). 3073–3083. 1 indexed citations

17.

Moxness, Michael, Mark Stene, Deborah Finco‐Kent, et al.. (2003). Development and Validation of Radioligand Binding Assays to Measure Total, IgA, IgE, IgG, and IgM Insulin Antibodies in Human Serum. Annals of the New York Academy of Sciences. 1005(1). 265–268. 12 indexed citations

18.

Basaria, Shehzad, Robert Udelsman, Javier Tejedor‐Sojo, William H. Westra, & Alan Krasner. (2002). Anaplastic pseudothyroiditis. Clinical Endocrinology. 56(4). 553–555. 16 indexed citations

19.

Krasner, Alan, Arunthathi Thiagalingam, Christopher T. Jones, et al.. (2000). Cloning and chromosomal localization of the human BARX2 homeobox protein gene. Gene. 250(1-2). 171–180. 20 indexed citations

20.

Krasner, Alan. (1999). Glucocorticoid-Induced Adrenal Insufficiency. JAMA. 282(7). 671–671. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact